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Abstract
Respiratory enzyme activities and steady-state level of two mitochondrial-encoded transcripts were quantified in heart
muscle biopsies from patients suffering various types of cardiomyopathies unrelated to mitochondrial primary disorders. We
have found that although the mitochondrial DNA copy number and the concentration of COI and ND4 transcripts remain
 .fairly constant, there is an important increase up to 6-fold in respiratory enzyme activities affecting to several oxidative
phosphorylation complexes. Idiopathic dilated cardiomyopathy shows the greatest increase, followed by ischemic heart and
ventricular hypertrophy due to aortic stenosis. The results suggest an energetic compensatory mechanism in the heart
muscle, in the absence of mitochondrial proliferation or activation of mitochondrial gene expression. q 1998 Elsevier
Science B.V.
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1. Introduction
Energy production in the heart largely relies upon
 .mitochondrial oxidative phosphorylation OXPHOS .
OXPHOS is made up by five enzyme complexes I
Abbreviations: COI, cytochrome c oxidase subunit I; ND4,
NADH dehydrogenase subunit 4; OXPHOS, oxidative phospho-
rylation; AS, aortic stenosis with normal transvalvular pressure
gradients; SAS, aortic stenosis with high transvalvular pressure
gradients; CI, coronary ischemia; IDC, idiopathic dilated car-
diomyopathy
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.through V under a dual genetic control: thirteen
polypeptides 7 subunits of complex I, 1 subunit of
complex III, 3 subunits of complex IV, and 2 sub-
.units of complex V as well as the ribosomal RNAs
and transfer RNAs are encoded by mitochondrial
 .DNA mtDNA , while all other proteins are encoded
 .by nuclear DNA nDNA , synthesized in the cyto-
w xplasm, and imported into the mitochondria 1 . ATP
synthesis is catalyzed by the multisubunit enzyme
 . qATP synthase complex V , coupled to the H gradi-
ent generated in the electron-transfer chain by Com-
 .plexes I, III and IV Fig. 1 . OXPHOS impairment
represents an increasingly recognized cause of car-
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Fig. 1. Schematic representation of the respiratory chain present in the inner mitochondrial membrane. The respiratory chain consists of
five different enzyme complexes embedded in the inner mitochondrial membrane, composed of about 80 polypeptides in total, 13 of them
 .  . encoded in the mtDNA and the rest in the nuclear genome: I NADH CoQ reductase , II Succinate CoQ reductase , III Ubiquinol
.  .  .cytochrome c reductase , IV Cytochrome c oxidase and V ATP synthase . In addition there are two small electron carriers, coenzyme
 .  .  .Q CoQ and Cytochrome c Cytc . The electrons from NADH and succinate are transferred to molecular oxygen 0 , through different2
redox groups bound to proteins present in the major complexes. CoQ and Cytc diffuse rapidly in the plane of the membrane and carry the
electrons between the different complexes. Part of the energy released in the process is used by complexes I, III and IV to pump Hq to
the intermembrane space, generating an electrochemical Hq gradient through the mitochondrial inner membrane. This gradient drives a
 .flux of protons back to the mitochondria through complex V ATP synthase , that is coupled to the synthesis of ATP.
diac failure, and evidence is accumulating that a
number of cardiomyopathies associated with OX-
w xPHOS defects are due to mtDNA mutations 2–6 .
On the other hand, dilated and ischemic heart have
been shown to alter OXPHOS activities or OXPHOS
w xgene expression 7–10 . However, there is not so far
a clear correlation between cardiac failure and OX-
PHOS function at enzymatic and molecular level,
since most of the studies have been focused in spe-
cific aspects of the ischemic or dilated heart. In this
report, we studied in parallel OXPHOS enzyme lev-
els, and OXPHOS gene expression in heart from
patients with various cardiomyopathies dilated, is-
.chemic, and valvular stenosis unrelated to primary
mitochondrial disorders.
2. Materials and methods
2.1. Patients
Myocardial biopsy specimens were obtained from
10 cardiac transplant recipients 9 men and 1 woman,
.aged 56"7 years , with idiopathic dilated cardiomy-
 .opathy IDC , from 8 male cardiac transplant recipi-
 .  .ents aged 50"8 years with coronary ischemia CI ,
and from 10 patients 8 men and 2 women aged
.57"10 years with left ventricular hypertrophy due
to aortic stenosis. Of the latter, five had normal
 .transvalvular pressure gradients AS patients and the
remaining showed high values for the gradient SAS
.patients .
All patients with IDC had New York Heart Asso-
 .ciation NYHA class IV congestive heart failure,
except one who had class III. The average left ven-
 .tricular ejection fraction was mean "SD 22"9.
Left ventricular end-diastolic volume index
 . y2LVEDVI was 198"20 ml m . Pulmonary capil-
 .lary wedge PCW was 20"5.
Patients with CI had NYHA functional class IV
congestive heart failure, except one who had class III.
Mean left ventricular ejection fraction was 23"6,
LVEDVI was 187"30 and PCW was 14"6.
Transvalvular pressure gradients in patients with
aortic stenosis ranged from 52 to 102 mmHg. Severe
aortic stenosis was considered when values for
transvalvular pressure gradients were above
80 mmHg. All patients with aortic stenosis belonged
to NYHA functional class II or I. Ejection fraction
was above 60% in all these patients. LVEDVI was
65"18. PCW was 11"4.
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Table 1
Oxphos and citrate synthase activities in heart muscle biopsies
a a a a bIq III II qIII II IV CS
 .Controls ns8 4.2"0.8 2.9"0.5 3.1"0.4 10.1"2.6 375"37
 .AS ns5 4.7"1.1 2.5"0.8 4.0"1.1 12.7"4.8 390"27
 .SAS ns5 12.4"3.9 4.9"2.2 5.7"1.2 19.7"6.1 379"24
 .CI ns8 11.4"3.1 4.6"1.7 5.9"1.4 15.8"4.0 386"50
 .IDC ns10 23.6"3.9 11.0"2.2 6.2"1.1 26.4"3.9 389"21
aRespiratory chain enzyme activities in mmol miny1 NCPy1 referred to the specific activity of CS
bCS activity is in mmol miny1 mg NCPy1
AS, Ventricular hypertrophy with normal transvalvular pressure gradient; SAS, ventricular hypertrophy with high transvalvular pressure
gradient; CI, Coronary Ischemia; IDC, Idiopatic dilated cardiomyopathy, NCP, Non Colagen Protein; CS, Citrate synthase. Values
represent mean "SD.
Left ventricular myocardial samples of transplant
recipients were taken after cross-clamping of the
aorta before the beginning of the cardiectomy. Biop-
sies of patients with AS and SAS were taken from
the left ventricle after the institution of cardiopul-
monary bypass before cross-clamping of the aorta.
Scaled-down endomyocardial biopsy specimens were
also obtained from 8 patients 6 men and 2 women,
.aged 42"14 years who underwent cardiac catheter-
ization under clinical suspicion of myocarditis, and
then proved to be free of heart disease. The tissue
was immediately frozen in liquid nitrogen and stored
for subsequent biochemical and molecular genetic
studies. Heart biopsies from controls were only used
for biochemical analysis since the amount of sample
available was extremely low.
2.2. Oxphos acti˝ities
Frozen myocardial biopsies were homogenized
with 15 volumes of 20 mM Potasium Phosphate buffer
 .pH 7.1 . The activities of the mitochondrial respira-
tory chain enzymes rotenone-sensitive NADH cy-
 .tochrome c reductase complexes Iq III , succinate
 .dehydrogenase complex II , succinate cytochrome c
 .reductase complexes IIq III , and cytochrome c
 .oxidase complex IV were measured in crude ho-
w xmogenates as described 11 , and normalized to the
activity of citrate synthase to correct to mitochondrial
w xvolume 3 . Non-collagen protein was determined as
w xreported 12 . To compare enzyme levels, one-way
variance analysis was used.
2.3. RNA extraction and northern analysis
Total RNA were extracted from frozen myocardial
biopsies following a protocol previously described
w x13 . For Northern blot hybridization total RNA was
electrophoresed on 1.2% agaroser1.8 M formal-
dehyde gels, blotted to Zeta-probe GT membrane
 .BioRad and probed with COI or ND4 specific
w 32 xclones labelled with a- P dCTP. The filters were
hybridized at 688C with the labelled probe in 7%
SDS, 0.5 M NaHP0 , 1 mM EDTA, washed at 658C4
in 0.5% SDS, 0.1 = SSC SSC: 0.15 M
.NaClr0.015 M sodium citrate , and autoradiographed
with intensify screens at y708C. To check the load-
ing of the gels, the membranes were rehybridized
Fig. 2. Quantification of ND4 and COI transcript level in heart
biopsies. ND4 and COI data are standarized with respect to 18S
rRNA and are presented in arbitrary units. The radioactivity of
the signals detected in the Northern analysis were quantified
 .using an instanimager Packard . The differences among the
different samples were not statistically significant.
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with a human 18S rDNA clone in the same condi-
tions described above. The radioactivity of the differ-
ent lanes were quantified using an instanimager
 .Packard . Statistical analysis was carried out using
the Kruskal–Wallis test. COI and ND4 clones were
respectively a 526 bp and a 410 bp fragments ob-
tained by PCR amplification with specific primers
 .and cloned in the vector pGEM-T Promega follow-
ing the manufacturers indications. The coordinates of
the primers in the human mtDNA Cambridge se-
 .quence accession number V00662 are: 6365–
6386r6891 – 6870 for COI and 11.289 –
11.310r11.699–11.678 for ND4.
3. Results
3.1. Number of mitochondria
Specific activities of CS were non significantly
different among the various groups of patients includ-
 .ing controls Table 1 , suggesting that in all the cases
there is no variation in the number of mitochondria.
This result was confirmed analyzing the steady-state
level of mtDNA present in the different samples.
Although the amount of mtDNA once standarized
respect to 18S rDNA shows some variability ranging
.from 0.6 to 2.6 arbitrary units there is not significant
differences between groups, with a mean value of
 .1.12"0.6 data not shown . In addition we have not
detected by Southern analysis deleted molecules in
w xaccordance with previous results 10 showing that
accumulation of deleted mtDNAs in ischemic hearts
 .is below 1% data not shown .
3.2. OXPHOS acti˝ities
Data on enzyme activities are shown in Table 1.
Compared to controls, the activities of all the my-
ocardial mitochondrial respiratory chain enzymes
were significantly higher in patients with IDC p-
.  .  .0.001 , with CI p-0.01 or with SAS p-0.01
 .but were similar in patients with AS Table 1 .
Values for all complexes were non significantly dif-
ferent between patients with CI and those with SAS.
However, levels of OXPHOS activities were signifi-
cantly greater in patients with CI or with SAS than in
 .those with AS p-0.05 . Patients with IDC, who
showed the highest levels for OXPHOS activities,
had significantly higher levels of all respiratory chain
 .complexes than those with AS p-0.001 . Also, in
patients with IDC, levels of enzyme complexes I, III
and IV were significantly higher than in those with
 .CI or with SAS p-0.01 , but the values for com-
plex II were not different.
3.3. Mitochondrial gene expression
We have quantified by Northern analysis the
steady-state level of two mitochondrial-encoded tran-
scripts, ND4 and COI, in total RNA extracted from
heart biopsies. Equivalent amount of RNA was loaded
in an agaroserformaldehyde gel and after transfer to
membranes were probed with the COI or ND4 spe-
cific clones. After washing out the radioactivity, the
same membranes were reprobed with a 18S rDNA
clone in order to check the loading of the gels see
.Section 2 . An example of the Northern analysis is
presented in Fig. 2, and a summary of the results in
Fig. 3. Northern blot analysis of the steady-state level of ND4 and COI transcripts. 10 mg of total RNA extracted from heart biopsies were
electrophoresed on 1.2% agaroser1.8 M formaldehyde gels, transferred to a nylon membrane and sequentially hybridized with the 32P
 .  .labelled COI A or ND4 B probes and a 18S rDNA probe. Lanes 1–3 ICD; lanes 4–8 CI; lanes 9–10 SAS.
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Fig. 3. By contrast with the important differences
detected at the level of enzyme activities, there is not
significant variations in the steady-state level ND4
 .  .p-0.19 or COI p-0.39 transcripts among the
different groups.
4. Discussion
We have analyzed the mtDNA content, mtDNA
gene expression and OXPHOS activities in patients
with different types of cardiopathies including IDC,
CI, SAS and AS. The values for CS, a mitochondrial
matrix enzyme, and noncollagen protein, did not
differ significantly in myocardium from patients and
controls, indicating that the number of mitochondria,
i.e. the mitochondrial volume, and the myocardial
fibrous content were similar in myocardial cells from
each group of patients. This result was fully con-
firmed by analysis of the mtDNA copy number, that
also remains constant. Since large-scale mtDNA dele-
tions have been previously documented in heart from
patients with idiopathic or ischemic cardiomyopathy,
we tested this possibility by performing Southern blot
analysis of myocardial mtDNA. We failed to detect
large mtDNA rearrangements, at least at the detection
limit of Southern blot analysis, i.e. around 1% of
deleted genomes. Most probably deleted mtDNA is
present at levels detectable only by PCR analysis, as
w xhas been previously described 10,14 . However it is
rather unlikely that such a very low proportions of
mutant genomes may cause any alteration in OX-
PHOS enzymes levels, because only deleted mtDNA
proportions over 60% result in respiratory chain
w xchanges 15 .
We have found a marked increase in OXPHOS
activities in myocardium from patients compared to
controls, ranging from 1.5- to 5.6-fold. Patients with
IDC showed the greatest increase while patients with
CI and those with SAS showed similar OXPHOS
activities that were intermediate between levels of
patients with IDC and normal controls. Moreover,
OXPHOS values for patients with AS were similar to
control values. Consistently, it has been shown that
the capacity of the mitochondrial respiratory chain
w xincreases with increasing hemodynamic stress 16 .
Our enzyme activity results contradict in part those
w xdocumented by Mauer and Zierz 9 , which noted a
reduction in activities in patients with coronary dis-
ease. The reasons of these discrepancies are un-
known, but might be related to differences in mito-
chondrial enzyme content of the myocardial tissue
analyzed. In particular, enzyme analysis in ho-
mogenates containing necrotic areas of myocardium
and their surrounding tissue may lead to an underesti-
mation of OXPHOS activities unpublished observa-
.tions . For this reason, before enzyme analysis we
eliminated those tissue areas from specimens of the
myocardium from CAD patients. Reduced OXPHOS
enzyme levels have also been documented in acute
w xmyocardial ischemia 17 , but our data came from
patients with coronary artery disease, a chronic is-
chemic disorder rather than an acute one.
OXPHOS enzyme levels either corrected for CS
activity or expressed as mg of NCP showed the same
relations among the groups. The similarity in CS
values suggests that the differences in OXPHOS lev-
els represent a direct effect on respiratory chain
rather than an alteration in the mitochondrial volume.
On the other hand, the variations observed were
nonspecific, and affected not only complexes contain-
ing mtDNA-encoded subunits, i.e. complexes I, III,
and IV, but those entirely contributed by nDNA, such
as complex II. It is plausible that an imbalance
between energy supply-demand relationship in dis-
eased myocardium may trigger these molecular re-
sponses in an attempt to compensate for the shortage
in energy. At this respect, levels of high-energy
phosphates were reduced in myocardial cells from
patients with aortic stenosis or with coronary is-
w xchemia 18 .
It has been previously reported in ischemic heart
an increase in the expression of OXPHOS genes
affecting both, nuclear and mitochondrial encoded
w x subunits 10 . The greatest increase up to roughly
.5-fold was detected in the nuclear encoded subunits,
while the increase in the 12S, 16S and Cytb were
 .more moderate roughly 2-fold . We have quantified
the steady-state level of two mitochondrial transcripts
encoding subunits of the respiratory complexes I
 .  .ND4 and IV COI and found that the concentration
of both transcripts remains constant in all the cases
tested, including IDC, CI, AS and SAS. Our results
indicate that the increase in the enzyme activities we
have detected in the different groups of patients is not
a direct consequence of an increase of gene dosage or
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an increase of mitochondrial gene expression, and
therefore is presumably due to increased level of
enzymes or an increase in the catalytic activity of
OXPHOS complexes. Further work is needed to dis-
tinguish between these two possibilities.
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